BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 21689221)

  • 1. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
    Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
    Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
    Namwanje H; Kabatereine N; Olsen A
    Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):181-8. PubMed ID: 21353271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
    Mohammed KA; Haji HJ; Gabrielli AF; Mubila L; Biswas G; Chitsulo L; Bradley MH; Engels D; Savioli L; Molyneux DH
    PLoS Negl Trop Dis; 2008 Jan; 2(1):e171. PubMed ID: 18235853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania.
    Massa K; Magnussen P; Sheshe A; Ntakamulenga R; Ndawi B; Olsen A
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):25-30. PubMed ID: 18771788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of albendazole for lymphatic filariasis.
    Horton J
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria.
    Eigege A; Pede E; Miri E; Umaru J; Ogbu Pearce P; Jinadu MY; Njepuome AN
    Ann Trop Med Parasitol; 2008 Mar; 102(2):177-9. PubMed ID: 18318940
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis.
    Olsen A
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):747-58. PubMed ID: 17481681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.
    Chami GF; Kabatereine NB; Tukahebwa EM
    BMC Med; 2019 Mar; 17(1):69. PubMed ID: 30917824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass drug treatment for lymphatic filariasis and onchocerciasis.
    Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
    Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.
    Dunyo SK; Nkrumah FK; Simonsen PE
    Trans R Soc Trop Med Hyg; 2000; 94(2):205-11. PubMed ID: 10897370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
    Eneanya OA; Gankpala L; Goss CW; Momolu AT; Nyan ES; Gray EB; Fischer K; Curtis K; Bolay FK; Weil GJ; Fischer PU
    Acta Trop; 2022 Jul; 231():106437. PubMed ID: 35405102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths.
    Olds GR; King C; Hewlett J; Olveda R; Wu G; Ouma J; Peters P; McGarvey S; Odhiambo O; Koech D; Liu CY; Aligui G; Gachihi G; Kombe Y; Parraga I; Ramirez B; Whalen C; Horton RJ; Reeve P
    J Infect Dis; 1999 Apr; 179(4):996-1003. PubMed ID: 10068597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.
    Hopkins DR; Eigege A; Miri ES; Gontor I; Ogah G; Umaru J; Gwomkudu CC; Mathai W; Jinadu M; Amadiegwu S; Oyenekan OK; Korve K; Richards FO
    Am J Trop Med Hyg; 2002 Sep; 67(3):266-72. PubMed ID: 12408665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
    Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages.
    Ndyomugyenyi R; Kabatereine N
    Trop Med Int Health; 2003 Nov; 8(11):997-1004. PubMed ID: 14629766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.